Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Home urine C-peptide creatinine ratio can be used to monitor islet transplant function.

Oram RA, Brooks AM, Forbes S, Eckoldt S, Smith RM, Choudhary P, Rosenthal MJ, Johnson P, Rutter MK, Burling KA, McDonald TJ, Shaw JA, Hattersley AT.

Diabetes Care. 2014 Jun;37(6):1737-40. doi: 10.2337/dc13-1266. Epub 2014 Mar 12.

PMID:
24623023
2.

Urine C-peptide creatinine ratio is a noninvasive alternative to the mixed-meal tolerance test in children and adults with type 1 diabetes.

Besser RE, Ludvigsson J, Jones AG, McDonald TJ, Shields BM, Knight BA, Hattersley AT.

Diabetes Care. 2011 Mar;34(3):607-9. doi: 10.2337/dc10-2114. Epub 2011 Feb 1.

3.

Urine C-peptide creatinine ratio is an alternative to stimulated serum C-peptide measurement in late-onset, insulin-treated diabetes.

Jones AG, Besser RE, McDonald TJ, Shields BM, Hope SV, Bowman P, Oram RA, Knight BA, Hattersley AT.

Diabet Med. 2011 Sep;28(9):1034-8. doi: 10.1111/j.1464-5491.2011.03272.x.

PMID:
21843301
4.
5.

The impact of gender on urine C-peptide creatinine ratio interpretation.

Thomas NJ, Shields BM, Besser RE, Jones AG, Rawlingson A, Goodchild E, Leighton C, Bowman P, Shepherd M, Knight BA, McDonald TJ, Hattersley AT.

Ann Clin Biochem. 2012 Jul;49(Pt 4):363-8. doi: 10.1258/acb.2011.011164. Epub 2012 May 8.

PMID:
22568974
6.

Clinical outcomes and insulin secretion after islet transplantation with the Edmonton protocol.

Ryan EA, Lakey JR, Rajotte RV, Korbutt GS, Kin T, Imes S, Rabinovitch A, Elliott JF, Bigam D, Kneteman NM, Warnock GL, Larsen I, Shapiro AM.

Diabetes. 2001 Apr;50(4):710-9.

7.

Home urine C-peptide creatinine ratio (UCPCR) testing can identify type 2 and MODY in pediatric diabetes.

Besser RE, Shields BM, Hammersley SE, Colclough K, McDonald TJ, Gray Z, Heywood JJ, Barrett TG, Hattersley AT.

Pediatr Diabetes. 2013 May;14(3):181-8. doi: 10.1111/pedi.12008. Epub 2013 Jan 4.

PMID:
23289766
8.

Validation of the BETA-2 Score: An Improved Tool to Estimate Beta Cell Function After Clinical Islet Transplantation Using a Single Fasting Blood Sample.

Forbes S, Oram RA, Smith A, Lam A, Olateju T, Imes S, Malcolm AJ, Shapiro AM, Senior PA.

Am J Transplant. 2016 Sep;16(9):2704-13. doi: 10.1111/ajt.13807. Epub 2016 Apr 21.

9.

Demonstration of an intrinsic relationship between endogenous C-peptide concentration and determinants of glycemic control in type 1 diabetes following islet transplantation.

Brooks AM, Oram R, Home P, Steen N, Shaw JA.

Diabetes Care. 2015 Jan;38(1):105-12. doi: 10.2337/dc14-1656. Epub 2014 Nov 24.

PMID:
25422169
10.

Beta-score: an assessment of beta-cell function after islet transplantation.

Ryan EA, Paty BW, Senior PA, Lakey JR, Bigam D, Shapiro AM.

Diabetes Care. 2005 Feb;28(2):343-7.

PMID:
15677790
11.

Beta cell function and ongoing autoimmunity in long-standing, childhood onset type 1 diabetes.

Williams GM, Long AE, Wilson IV, Aitken RJ, Wyatt RC, McDonald TJ, Wong FS, Hattersley AT, Williams AJ, Bingley PJ, Gillespie KM.

Diabetologia. 2016 Dec;59(12):2722-2726. Epub 2016 Sep 3.

PMID:
27591853
12.

Urine C-peptide creatinine ratio can be used to assess insulin resistance and insulin production in people without diabetes: an observational study.

Oram RA, Rawlingson A, Shields BM, Bingham C, Besser RE, McDonald TJ, Knight BA, Hattersley AT.

BMJ Open. 2013 Dec 18;3(12):e003193. doi: 10.1136/bmjopen-2013-003193.

13.

Simple measures to monitor beta-cell mass and assess islet graft dysfunction.

Faradji RN, Monroy K, Messinger S, Pileggi A, Froud T, Baidal DA, Cure PE, Ricordi C, Luzi L, Alejandro R.

Am J Transplant. 2007 Feb;7(2):303-8. Epub 2006 Dec 6.

14.

Five-year follow-up after clinical islet transplantation.

Ryan EA, Paty BW, Senior PA, Bigam D, Alfadhli E, Kneteman NM, Lakey JR, Shapiro AM.

Diabetes. 2005 Jul;54(7):2060-9.

15.

Stability and reproducibility of a single-sample urinary C-peptide/creatinine ratio and its correlation with 24-h urinary C-peptide.

McDonald TJ, Knight BA, Shields BM, Bowman P, Salzmann MB, Hattersley AT.

Clin Chem. 2009 Nov;55(11):2035-9. doi: 10.1373/clinchem.2009.129312. Epub 2009 Aug 27.

16.

Urinary C-Peptide/Creatinine Ratio Can Distinguish Maturity-Onset Diabetes of the Young from Type 1 Diabetes in Children and Adolescents: A Single-Center Experience.

Yılmaz Agladioglu S, Sagsak E, Aycan Z.

Horm Res Paediatr. 2015;84(1):54-61. doi: 10.1159/000375410. Epub 2015 Mar 17.

PMID:
25792383
17.

Achievement of insulin independence in three consecutive type-1 diabetic patients via pancreatic islet transplantation using islets isolated at a remote islet isolation center.

Goss JA, Schock AP, Brunicardi FC, Goodpastor SE, Garber AJ, Soltes G, Barth M, Froud T, Alejandro R, Ricordi C.

Transplantation. 2002 Dec 27;74(12):1761-6.

PMID:
12499894
18.

Transplanted functional islet mass: donor, islet preparation, and recipient factors influence early graft function in islet-after-kidney patients.

Friberg AS, Lundgren T, Malm H, Felldin M, Nilsson B, Jenssen T, Kyllönen L, Tufveson G, Tibell A, Korsgren O.

Transplantation. 2012 Mar 27;93(6):632-8. doi: 10.1097/TP.0b013e3182455912.

PMID:
22258287
19.

Attainment of metabolic goals in the integrated UK islet transplant program with locally isolated and transported preparations.

Brooks AM, Walker N, Aldibbiat A, Hughes S, Jones G, de Havilland J, Choudhary P, Huang GC, Parrott N, McGowan NW, Casey J, Mumford L, Barker P, Burling K, Hovorka R, Walker M, Smith RM, Forbes S, Rutter MK, Amiel S, Rosenthal MJ, Johnson P, Shaw JA.

Am J Transplant. 2013 Dec;13(12):3236-43. doi: 10.1111/ajt.12469. Epub 2013 Oct 1.

20.

Most people with long-duration type 1 diabetes in a large population-based study are insulin microsecretors.

Oram RA, McDonald TJ, Shields BM, Hudson MM, Shepherd MH, Hammersley S, Pearson ER, Hattersley AT; UNITED Team.

Diabetes Care. 2015 Feb;38(2):323-8. doi: 10.2337/dc14-0871. Epub 2014 Dec 17.

Supplemental Content

Support Center